[1]. E. C. Eichenwald A. R. Stark 2008 Management and outcomes of very low birth weight N. Engl. J. Med. 358 1700–1711.

[1]. E. C. Eichenwald A. R. Stark 2008 Management and outcomes of very low birth weight N. Engl. J. Med. 358 1700–1711.)| false
• Search Google Scholar
• Export Citation

[2]. M. C. Walsh Q. Yao P. Gettner et al.2004 Impact of a physiologic definition on bronchopulmonary dysplasia rates Pediatrics 114 1305–1311.

[2]. M. C. Walsh Q. Yao P. Gettner 2004 Impact of a physiologic definition on bronchopulmonary dysplasia rates Pediatrics 114 1305–1311.)| false
• Search Google Scholar
• Export Citation

[3]. A. A. Fanaroff B. J. Stoll L. L. Wright et al.2007 Trends in neonatal morbidity and mortality for very low birthweight infants Am. J. Obstet. Gynecol. 196 2 147.e1–147.e8.

[3]. A. A. Fanaroff B. J. Stoll L. L. Wright 2007 Trends in neonatal morbidity and mortality for very low birthweight infants Am. J. Obstet. Gynecol. 196 2 147.e1–147.e8.)| false
• Search Google Scholar
• Export Citation

[4]. L. Genen J. M. Davis 2006 Chronic Lung Disease: Etiology and Pathogenesis S.M. Donn S.K. Sinha Manual of Neonatal Respiratory Care Mosby Elsevier USA 358.

[4]. L. Genen J. M. Davis 2006 Chronic Lung Disease: Etiology and Pathogenesis S.M. Donn S.K. Sinha Manual of Neonatal Respiratory Care Mosby Elsevier USA 358.)| false
• Search Google Scholar
• Export Citation

[5]. E. Baraldi M. Filippone 2007 Chronic lung disease after premature birth N. Engl. J. Med. 357 1946–1955.

[5]. E. Baraldi M. Filippone 2007 Chronic lung disease after premature birth N. Engl. J. Med. 357 1946–1955.)| false
• Search Google Scholar
• Export Citation

[6]. E. J. Short N. K. Klein B. A. Lewis et al.2003 Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes Pediatrics 112 5 359.

[6]. E. J. Short N. K. Klein B. A. Lewis 2003 Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes Pediatrics 112 5 359.)| false
• Search Google Scholar
• Export Citation

[7]. S. Saigal 2006 Long-Term Outcomes of Newborns with Chronic Lung Disease S.M. Donn S.K. Sinha Manual of Neonatal Respiratory Care Mosby Elsevier USA 370–373.

[7]. S. Saigal 2006 Long-Term Outcomes of Newborns with Chronic Lung Disease S.M. Donn S.K. Sinha Manual of Neonatal Respiratory Care Mosby Elsevier USA 370–373.)| false
• Search Google Scholar
• Export Citation

[8]. R. Antonucci P. Contu A. Porcella et al.2004 Intrauterine smoke exposure: new risk factor for bronchpulmonary dysplasia? J. Perinat. Med. 32 272–277.

[8]. R. Antonucci P. Contu A. Porcella 2004 Intrauterine smoke exposure: new risk factor for bronchpulmonary dysplasia? J. Perinat. Med. 32 272–277.)| false
• Search Google Scholar
• Export Citation

[9]. E. C. Eichenwald A. R. Stark 2006 Pulmonary inflammation and bronchopulmonary dysplasia J. Perinatol. 26 Suppl 57–62.

[9]. E. C. Eichenwald A. R. Stark 2006 Pulmonary inflammation and bronchopulmonary dysplasia J. Perinatol. 26 Suppl 57–62.)| false
• Search Google Scholar
• Export Citation

[10]. R. Ramanathan S. Sardesai 2008 Lung protective ventilatory strategies in very low birth weight infants J. Perinatol. 28 Suppl1 41–46.

[10]. R. Ramanathan S. Sardesai 2008 Lung protective ventilatory strategies in very low birth weight infants J. Perinatol. 28 Suppl1 41–46.)| false
• Search Google Scholar
• Export Citation

[11]. L.J. Van Marter E.N. Allred M. Pagano et al.2000 Do clinical markers of barotraumas and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 105 1194–1197.

[11]. L.J. Van Marter E.N. Allred M. Pagano 2000 Do clinical markers of barotraumas and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 105 1194–1197.)| false
• Search Google Scholar
• Export Citation

[12]. L. M. Askie D. J. Henderson-Smart L. Irwing et al.2003 Oxygen-saturation targets and outcomes in extremely preterm infants N. Engl. J. Med. 349 959–967.

[12]. L. M. Askie D. J. Henderson-Smart L. Irwing 2003 Oxygen-saturation targets and outcomes in extremely preterm infants N. Engl. J. Med. 349 959–967.)| false
• Search Google Scholar
• Export Citation

[13]. A. H. Jobe 1993 Pulmonary surfactant therapy N. Engl. J. Med. 328 861–865.

[13]. A. H. Jobe 1993 Pulmonary surfactant therapy N. Engl. J. Med. 328 861–865.)| false
• Search Google Scholar
• Export Citation

[14]. D. Patel A. Greenough 2008 Does nasal CPAP reduce bronchopulmonary dysplasia (BPD)? Acta Paediatr. 97 10 1314–1317.

[14]. D. Patel A. Greenough 2008 Does nasal CPAP reduce bronchopulmonary dysplasia (BPD)? Acta Paediatr. 97 10 1314–1317.)| false
• Search Google Scholar
• Export Citation

[15]. A. J. Squires M. Hyndman 2009 Prevention of nasal injuries secondary to NCPAP application in the ELBW infant Neonatal Netw 28 1 13–27.

[15]. A. J. Squires M. Hyndman 2009 Prevention of nasal injuries secondary to NCPAP application in the ELBW infant Neonatal Netw 28 1 13–27.)| false
• Search Google Scholar
• Export Citation

[16]. A. A. Fanaroff R. J. Martin 2006 Neonatal-Perinatal Medicine 8 Mosby Inc. Philadelphia USA 1155–1165.

[16]. A. A. Fanaroff R. J. Martin 2006 Neonatal-Perinatal Medicine 8 Mosby Inc. Philadelphia USA 1155–1165.)| false
• Search Google Scholar
• Export Citation

[17]. J. S. Garland R. K. Buck E. N. Allred et al.1995 Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome Arch. Pediatr. Adolesc. Med. 149 617–622.

[17]. J. S. Garland R. K. Buck E. N. Allred 1995 Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome Arch. Pediatr. Adolesc. Med. 149 617–622.)| false
• Search Google Scholar
• Export Citation

[18]. P. S. Shah V. Shah Z. Qiu et al.2005 Improved outcomes of outborn preterm infants if admitted to perinatal centers versus freestanding pediatric hospitals J. Pediatr. 146 626–631.

[18]. P. S. Shah V. Shah Z. Qiu 2005 Improved outcomes of outborn preterm infants if admitted to perinatal centers versus freestanding pediatric hospitals J. Pediatr. 146 626–631.)| false
• Search Google Scholar
• Export Citation

[19]. C. S. Phibbs L. C. Baker A. B. Caughey et al.2007 Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants N. Engl. J. Med. 356 2165–2175.

[19]. C. S. Phibbs L. C. Baker A. B. Caughey 2007 Level and volume of neonatal intensive care and mortality in very-low-birth-weight infants N. Engl. J. Med. 356 2165–2175.)| false
• Search Google Scholar
• Export Citation

[20]. D. B. Bartels D. Wypij P. Wenzlaff et al.2006 Hospital volume and neonatal mortality among very low birth weight infants Pediatrics 117 2206–14.

[20]. D. B. Bartels D. Wypij P. Wenzlaff 2006 Hospital volume and neonatal mortality among very low birth weight infants Pediatrics 117 2206–14.)| false
• Search Google Scholar
• Export Citation

[21]. R. A. Ehrenkranz M. C. Walsh B. R. Vohr et al.2005 Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia Pediatrics 116 1353–1360.

[21]. R. A. Ehrenkranz M. C. Walsh B. R. Vohr 2005 Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia Pediatrics 116 1353–1360.)| false
• Search Google Scholar
• Export Citation

[22]. P. von Bismarck A. Claass C. Schickor et al.2008 Altered pulmonary interleukin-6 signaling in preterm infants developing bronchopulmonary dysplasia Exp. Lung Res. 34 10 694–706.

[22]. P. von Bismarck A. Claass C. Schickor 2008 Altered pulmonary interleukin-6 signaling in preterm infants developing bronchopulmonary dysplasia Exp. Lung Res. 34 10 694–706.)| false
• Search Google Scholar
• Export Citation

[23]. Kotecha, S.: Cytokines in chronic lung disease of prematurity. Eur. J. Pediatr., 1996 Aug, Suppl 2, 14–17.

[23]. Kotecha, S.: Cytokines in chronic lung disease of prematurity. Eur. J. Pediatr., 1996 Aug, Suppl 2, 14–17.)| false
• Search Google Scholar
• Export Citation

[24]. C. W. Choi B. I. Kim H. S. Kim et al.2006 Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants Acta Paediatr. 95 1 38–43.

[24]. C. W. Choi B. I. Kim H. S. Kim 2006 Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants Acta Paediatr. 95 1 38–43.)| false
• Search Google Scholar
• Export Citation

[25]. S. N. Kazzi R. Romero K. McLaughlin et al.2001 Serial changes in levels of IL-6 and IL-1beta in premature infants at risk for bronchopulmonary dysplasia Pediatr. Pulmonol. 31 3 220–226.

[25]. S. N. Kazzi R. Romero K. McLaughlin 2001 Serial changes in levels of IL-6 and IL-1beta in premature infants at risk for bronchopulmonary dysplasia Pediatr. Pulmonol. 31 3 220–226.)| false
• Search Google Scholar
• Export Citation

[26]. G. Bokodi A. Treszl L. Kovács et al.2007 Dysplasia: a review Pediatr. Pulmonol. 42 10 952–961.

[26]. G. Bokodi A. Treszl L. Kovács 2007 Dysplasia: a review Pediatr. Pulmonol. 42 10 952–961.)| false
• Search Google Scholar
• Export Citation

[27]. B. H. Yoon R. Romero K. S. Kim et al.2001 Systemic fetal inflammatory response and the development of bronchopulmonary dysplasia Am. J. Obstet. Gynecol. 184 7 1584–1585.

[27]. B. H. Yoon R. Romero K. S. Kim 2001 Systemic fetal inflammatory response and the development of bronchopulmonary dysplasia Am. J. Obstet. Gynecol. 184 7 1584–1585.)| false
• Search Google Scholar
• Export Citation

[28]. R. Mittendorf R. Covert A. G. Montag et al.2005 Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates J. Perinat. Med. 33 5 428–434.

[28]. R. Mittendorf R. Covert A. G. Montag 2005 Special relationships between fetal inflammatory response syndrome and bronchopulmonary dysplasia in neonates J. Perinat. Med. 33 5 428–434.)| false
• Search Google Scholar
• Export Citation

[29]. R. M. Viscardi C. K. Muhumuza A. Rodriguez et al.2004 Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants Pediatr. Res. 55 6 1009–1017.

[29]. R. M. Viscardi C. K. Muhumuza A. Rodriguez 2004 Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants Pediatr. Res. 55 6 1009–1017.)| false
• Search Google Scholar
• Export Citation

[30]. E. J. Hayes D. A. Paul G. E. Stahl et al.2008 Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation Obstet. Gynecol. 111 4 921–926.

[30]. E. J. Hayes D. A. Paul G. E. Stahl 2008 Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation Obstet. Gynecol. 111 4 921–926.)| false
• Search Google Scholar
• Export Citation

[31]. P. Mazumder S. Dutta J. Kaur et al.2008 Single versus multiple courses of antenatal betamethasone and neonatal outcome: a randomized controlled trial Indian Pediatr. 45 8 650–652.

[31]. P. Mazumder S. Dutta J. Kaur 2008 Single versus multiple courses of antenatal betamethasone and neonatal outcome: a randomized controlled trial Indian Pediatr. 45 8 650–652.)| false
• Search Google Scholar
• Export Citation

[32]. M. J. Finken M. G. Keijzer-Veen F. W. Dekker et al.2008 Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation Arch. Dis. Child Fetal Neonatal. 93 6 F442–F447.

[32]. M. J. Finken M. G. Keijzer-Veen F. W. Dekker 2008 Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation Arch. Dis. Child Fetal Neonatal. 93 6 F442–F447.)| false
• Search Google Scholar
• Export Citation

[33]. [No authors listed] Antenatal betamethasone: reassuring long-term data. Prescrire Int., 2008 Apr, 17(94), 73.

[34]. C. McEvoy D. Schilling P. Spitale et al.2008 Decreased respiratory compliance in infants less than or equal to 32 weeks’ gestation, delivered more than 7 days after antenatal steroid therapy Pediatrics 121 5 1032–1038.

[34]. C. McEvoy D. Schilling P. Spitale 2008 Decreased respiratory compliance in infants less than or equal to 32 weeks’ gestation, delivered more than 7 days after antenatal steroid therapy Pediatrics 121 5 1032–1038.)| false
• Search Google Scholar
• Export Citation

[35]. J. D. Pole C. A. Mustard T. To et al.2009 Antenatal steroid therapy for fetal lung maturation: is there an association with childhood asthma? J. Asthma. 46 1 47–52.

[35]. J. D. Pole C. A. Mustard T. To 2009 Antenatal steroid therapy for fetal lung maturation: is there an association with childhood asthma? J. Asthma. 46 1 47–52.)| false
• Search Google Scholar
• Export Citation

[36]. O. Teksam G. Kale 2008 The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome Pediatrics 121 2 419–432.

[36]. O. Teksam G. Kale 2008 The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome Pediatrics 121 2 419–432.)| false
• Search Google Scholar
• Export Citation

[37]. W. A. Engle 2009 Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. American Academy of Pediatrics Committee on Fetus and Newborn Pathol. Res. Pract. 205 1 35–41.

[37]. W. A. Engle 2009 Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. American Academy of Pediatrics Committee on Fetus and Newborn Pathol. Res. Pract. 205 1 35–41.)| false
• Search Google Scholar
• Export Citation

[38]. R. Ramanathan 2007 Early surfactant therapy and noninvasive ventilation J. Perinat. 27 S33–37.

[38]. R. Ramanathan 2007 Early surfactant therapy and noninvasive ventilation J. Perinat. 27 S33–37.)| false
• Search Google Scholar
• Export Citation

[39]. D. G. Grier H. L. Halliday 2005 Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use Drugs 65 1 15–29.

[39]. D. G. Grier H. L. Halliday 2005 Management of bronchopulmonary dysplasia in infants: guidelines for corticosteroid use Drugs 65 1 15–29.)| false
• Search Google Scholar
• Export Citation

[40]. S. J. Gross R. D. Anbar B. B. Mettelman 2005 Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease Pediatrics 115 3 681–687.

[40]. S. J. Gross R. D. Anbar B. B. Mettelman 2005 Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease Pediatrics 115 3 681–687.)| false
• Search Google Scholar
• Export Citation

[41]. P. A. Nixon L. K. Washburn M. S. Schechter et al.2007 Follow-up study of a randomized controlled trial of postnatal dexamethason therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years J. Pediatr. 150 345–350.

[41]. P. A. Nixon L. K. Washburn M. S. Schechter 2007 Follow-up study of a randomized controlled trial of postnatal dexamethason therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years J. Pediatr. 150 345–350.)| false
• Search Google Scholar
• Export Citation

[42]. M. Varughese S. Patole A. Shama et al.2002 Permissive hypercapnia in neonates: the case of the good, the bad, and the ugly Pediatr. Pulmonol. 33 1 56–64.

[42]. M. Varughese S. Patole A. Shama 2002 Permissive hypercapnia in neonates: the case of the good, the bad, and the ugly Pediatr. Pulmonol. 33 1 56–64.)| false
• Search Google Scholar
• Export Citation

[43]. R. L. Auten M. Vozzelli R. H. Clark 2001 Volutrauma. What is it, and how do we avoid it? Clin. Perinatol. 28 3 505–515.

[43]. R. L. Auten M. Vozzelli R. H. Clark 2001 Volutrauma. What is it, and how do we avoid it? Clin. Perinatol. 28 3 505–515.)| false
• Search Google Scholar
• Export Citation

[44]. W. A. Carlo A. R. Stark L. L. Wright et al.2002 Minimal ventilation to prevent bronchopulmonary dysplasia in extremely low birth weight infants J. Pediatr. 141 370–374.

[44]. W. A. Carlo A. R. Stark L. L. Wright 2002 Minimal ventilation to prevent bronchopulmonary dysplasia in extremely low birth weight infants J. Pediatr. 141 370–374.)| false
• Search Google Scholar
• Export Citation

[45]. J. D. Miller W. A. Carlo 2007 Safety and effectiveness of permissive hypercapnia in the preterm infant Curr. Opin. Pediatr. 19 142–144.

[45]. J. D. Miller W. A. Carlo 2007 Safety and effectiveness of permissive hypercapnia in the preterm infant Curr. Opin. Pediatr. 19 142–144.)| false
• Search Google Scholar
• Export Citation

[46]. H. Aly A. N. Massaro K. Patel et al.2005 Is it safer to intubate premature infants in the delivery room? Pediatrics 115 1660–1665.

[46]. H. Aly A. N. Massaro K. Patel 2005 Is it safer to intubate premature infants in the delivery room? Pediatrics 115 1660–1665.)| false
• Search Google Scholar
• Export Citation

[47]. L. Kirchner M. Weninger L. Unterasinger et al.2005 Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years of experience with the vermont Oxford Neonatal Network J. Perinat. Med. 33 60–66.

[47]. L. Kirchner M. Weninger L. Unterasinger 2005 Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years of experience with the vermont Oxford Neonatal Network J. Perinat. Med. 33 60–66.)| false
• Search Google Scholar
• Export Citation

[48]. A. Greenough 2007 Appropriate ventilation of the preterm newborn J. Perinat. Med. 35 25–26.

[48]. A. Greenough 2007 Appropriate ventilation of the preterm newborn J. Perinat. Med. 35 25–26.)| false
• Search Google Scholar
• Export Citation

[49]. A. Greenough 2008 Emerging drugs for the prevention of bronchopulmonary dysplasia Exp. Opin. Emerg. Drugs 13 3 537–546.

[49]. A. Greenough 2008 Emerging drugs for the prevention of bronchopulmonary dysplasia Exp. Opin. Emerg. Drugs 13 3 537–546.)| false
• Search Google Scholar
• Export Citation

[50]. Darlow, B. A., Graham, P. J.: Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst. Rev., 2007, Issue 3, Art. No.: CD000501. DOI: 10.1002/14651858.CD000501.pub2.

[50]. Darlow, B. A., Graham, P. J.: Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst. Rev., 2007, Issue 3, Art. No.: CD000501. DOI: 10.1002/14651858.CD000501.pub2.)| false
• Search Google Scholar
• Export Citation

[51]. P. S. Shah 2003 Current perspectives on the prevention and management of chronic lung disease in preterm infants Paediatr. Drugs. 5 7 463–480.

[51]. P. S. Shah 2003 Current perspectives on the prevention and management of chronic lung disease in preterm infants Paediatr. Drugs. 5 7 463–480.)| false
• Search Google Scholar
• Export Citation

[52]. E. E. Ziegler 2007 Aggressive nutrition of VLBW infants J. Perinat. Med. 35 54–55.

[52]. E. E. Ziegler 2007 Aggressive nutrition of VLBW infants J. Perinat. Med. 35 54–55.)| false
• Search Google Scholar
• Export Citation

[53]. M. A. Biniwale R. A. Ehrenkranz 2006 The role of nutrition in the prevention and management of bronchopulmonary dysplasia Semin. Perinatol. 30 4 200–208.

[53]. M. A. Biniwale R. A. Ehrenkranz 2006 The role of nutrition in the prevention and management of bronchopulmonary dysplasia Semin. Perinatol. 30 4 200–208.)| false
• Search Google Scholar
• Export Citation

[54]. Viscardi, R. M., Hasday, J. D.: Role of Ureaplasma species in Neonatal Chronic Lung Disease: Epidemiologic and Experimental Evidence. Pediatr. Res., 2009, Jan.28.

[54]. Viscardi, R. M., Hasday, J. D.: Role of Ureaplasma species in Neonatal Chronic Lung Disease: Epidemiologic and Experimental Evidence. Pediatr. Res., 2009, Jan.28.)| false
• Search Google Scholar
• Export Citation

[55]. R. Paananen A. K. Husa R. Vuolteenaho et al.2009 Blood Cytokines during the Perinatal Period in Very Preterm Infants: Relationship of Inflammatory Response and Bronchopulmonary Dysplasia J. Pediatr. 154 1 39–43.e3.

[55]. R. Paananen A. K. Husa R. Vuolteenaho 2009 Blood Cytokines during the Perinatal Period in Very Preterm Infants: Relationship of Inflammatory Response and Bronchopulmonary Dysplasia J. Pediatr. 154 1 39–43.e3.)| false
• Search Google Scholar
• Export Citation

[56]. G. Kewitz S. Wudel H. Hopp et al.2008 Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia J. Perinat. Med. 36 359–364.

[56]. G. Kewitz S. Wudel H. Hopp 2008 Below median birth weight in appropriate-for-gestational-age preterm infants as a risk factor for bronchopulmonary dysplasia J. Perinat. Med. 36 359–364.)| false
• Search Google Scholar
• Export Citation

[57]. A. Greenough 2008 Long-term pulmonary outcome in the preterm infant Neonatology 93 324–327.

[57]. A. Greenough 2008 Long-term pulmonary outcome in the preterm infant Neonatology 93 324–327.)| false
• Search Google Scholar
• Export Citation